Loading...

Kronos Bio ($KRON)

Stock Image

KRON Overview

Kronos Bio, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics.The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib, a selective inhibitor targeting spleen tyrosine kinase in acute myeloid leukemia patients.The company is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors.Kronos Bio, Inc. is founded in 2017 and is headquartered in San Mateo, California. (From: StockAnalysis.com)

MORE ABOUT Kronos Bio

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.